ConductScience.org, home

Paper22720237

Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor Development.

Donkor MK and 2 others. Oncoimmunology, 2012. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor Development. Papers, record 22720237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22720237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor Development.
PubMed
Journal
Oncoimmunology
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
0.94
iCite
Revised in PubMed
2021-10-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Donkor MKMoses K
2Sarkar AAbira
3Li MOMing O

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112482908Making sense of latent TGFbeta activation.J Cell Sci2003https://conductscience.org/library/papers/12482908PubMed
218026089Adaptive immunity maintains occult cancer in an equilibrium state.Nature2007https://conductscience.org/library/papers/18026089PubMed
318173375PD-1 and its ligands in tolerance and immunity.Annu Rev Immunol2008https://conductscience.org/library/papers/18173375PubMed
41436033Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.Nature1992https://conductscience.org/library/papers/1436033PubMed
517481928T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.Immunity2007https://conductscience.org/library/papers/17481928PubMed
612093877Suppression of lymphoma and epithelial malignancies effected by interferon gamma.J Exp Med2002https://conductscience.org/library/papers/12093877PubMed
716973386Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.Immunity2006https://conductscience.org/library/papers/16973386PubMed
816973387Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor.Immunity2006https://conductscience.org/library/papers/16973387PubMed
911590434Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.Nat Med2001https://conductscience.org/library/papers/11590434PubMed
104921480The concept of immunological surveillance.Prog Exp Tumor Res1970https://conductscience.org/library/papers/4921480PubMed
1118684640Specificity in cancer immunotherapy.Semin Immunol2008https://conductscience.org/library/papers/18684640PubMed
1218692464TGF-beta: a master of all T cell trades.Cell2008https://conductscience.org/library/papers/18692464PubMed
13194247Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/194247PubMed
1416286245TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance.Cancer Cell2005https://conductscience.org/library/papers/16286245PubMed
1511323675IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.Nature2001https://conductscience.org/library/papers/11323675PubMed
1617895374Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17895374PubMed
1721757379T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.Immunity2011https://conductscience.org/library/papers/21757379PubMed
1815753372Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.Cancer Res2005https://conductscience.org/library/papers/15753372PubMed
1917312132Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta.J Immunol2007https://conductscience.org/library/papers/17312132PubMed
208811491Modulation of B16 melanoma growth and metastasis by anti-transforming growth factor beta antibody and interleukin-2.J Immunother Emphasis Tumor Immunol1996https://conductscience.org/library/papers/8811491PubMed

See all 45 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
40787250Identification of immune escape-related prognostic genes and immune infiltration analysis in hepatocellular carcinoma based on bioinformatics.Biochem Biophys Rep2025https://conductscience.org/library/papers/40787250PubMed
38514615TGF-β signaling in health, disease, and therapeutics.Signal Transduct Target Ther2024https://conductscience.org/library/papers/38514615PubMed
38376927Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer.JCI Insight2024https://conductscience.org/library/papers/38376927PubMed
36650384Molecular and therapeutic effect of CRISPR in treating cancer.Med Oncol2023https://conductscience.org/library/papers/36650384PubMed
36417079Progress in the relationship between P2X7R and colorectal cancer.Mol Biol Rep2023https://conductscience.org/library/papers/36417079PubMed
36382146TGFβ: Signaling Blockade for Cancer Immunotherapy.Annu Rev Cancer Biol2022https://conductscience.org/library/papers/36382146PubMed
36380023TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective.Nat Rev Immunol2023https://conductscience.org/library/papers/36380023PubMed
36326892Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor.Cancer Immunol Immunother2023https://conductscience.org/library/papers/36326892PubMed
36229613TGF-β-dependent lymphoid tissue residency of stem-like T cells limits response to tumor vaccine.Nat Commun2022https://conductscience.org/library/papers/36229613PubMed
36072935The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36072935PubMed
36003368Metabolic rewiring directs melanoma immunology.Front Immunol2022https://conductscience.org/library/papers/36003368PubMed
34834295Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design.Pharmaceutics2021https://conductscience.org/library/papers/34834295PubMed
34780568The differentiation state of the Schwann cell progenitor drives phenotypic variation between two contagious cancers.PLoS Pathog2021https://conductscience.org/library/papers/34780568PubMed
34305041Immunity beyond cancer cells: perspective from tumor tissue.Trends Cancer2021https://conductscience.org/library/papers/34305041PubMed
33974997Self-driving armored CAR-T cells overcome a suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical models.Mol Ther2021https://conductscience.org/library/papers/33974997PubMed
33828560Frequency of Effector Memory Cells Expressing Integrin α4β7 Is Associated With TGF-β1 Levels in Therapy Naïve HIV Infected Women With Low CD4+ T Cell Count.Front Immunol2021https://conductscience.org/library/papers/33828560PubMed
33771888A tumor-specific mechanism of Treg enrichment mediated by the integrin αvβ8.Sci Immunol2021https://conductscience.org/library/papers/33771888PubMed
33717139The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies.Front Immunol2021https://conductscience.org/library/papers/33717139PubMed
33087928TGF-β suppresses type 2 immunity to cancer.Nature2020https://conductscience.org/library/papers/33087928PubMed
32710082TGFβ biology in cancer progression and immunotherapy.Nat Rev Clin Oncol2021https://conductscience.org/library/papers/32710082PubMed

See all 28 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TGFBR27048PubTator's text mininghttps://conductscience.org/library/genes/7048NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22720237

GET https://conductscience.org/api/papers/v1/22720237/references?page=2